Anthony Markham

1.0k total citations
10 papers, 814 citations indexed

About

Anthony Markham is a scholar working on Pharmacology, Oncology and Infectious Diseases. According to data from OpenAlex, Anthony Markham has authored 10 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Anthony Markham's work include Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer therapeutics and mechanisms (1 paper) and Immune Cell Function and Interaction (1 paper). Anthony Markham is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer therapeutics and mechanisms (1 paper) and Immune Cell Function and Interaction (1 paper). Anthony Markham collaborates with scholars based in New Zealand. Anthony Markham's co-authors include Rick Davis, Julia A. Balfour, Lynda R. Wiseman, Mukta Dooley, Heather D. Langtry, Rex N. Brogden, Kerryn L. Simpson and Zaina T. Al-Salama and has published in prestigious journals such as Drugs, CNS Drugs and Drugs & Aging.

In The Last Decade

Anthony Markham

10 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Markham New Zealand	9	204	175	114	113	113	10	814
Susan M. Cheer New Zealand	18	206 1.0×	136 0.8×	121 1.1×	165 1.5×	89 0.8×	30	1.1k
Keri Wellington New Zealand	26	271 1.3×	329 1.9×	208 1.8×	170 1.5×	168 1.5×	54	1.9k
Rick Davis United States	14	470 2.3×	204 1.2×	207 1.8×	125 1.1×	99 0.9×	25	1.5k
William A. Wargin United States	23	408 2.0×	249 1.4×	150 1.3×	177 1.6×	308 2.7×	54	1.9k
G.J. Krol United States	18	398 2.0×	190 1.1×	152 1.3×	68 0.6×	151 1.3×	37	1.1k
Ondřej Slanař Czechia	21	193 0.9×	301 1.7×	94 0.8×	164 1.5×	152 1.3×	162	1.3k
Supakanya Wongrakpanich United States	10	190 0.9×	136 0.8×	67 0.6×	119 1.1×	63 0.6×	24	982
Eppo van der Kleijn Netherlands	24	274 1.3×	258 1.5×	83 0.7×	52 0.5×	170 1.5×	66	1.5k
Mohammed H. Elkomy Egypt	25	242 1.2×	366 2.1×	95 0.8×	81 0.7×	98 0.9×	71	1.8k
Denis Lamiable France	16	168 0.8×	125 0.7×	48 0.4×	48 0.4×	76 0.7×	73	770

Countries citing papers authored by Anthony Markham

Since Specialization

Citations

This map shows the geographic impact of Anthony Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Markham more than expected).

Fields of papers citing papers by Anthony Markham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Markham. The network helps show where Anthony Markham may publish in the future.

Co-authorship network of co-authors of Anthony Markham

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Markham. A scholar is included among the top collaborators of Anthony Markham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Markham. Anthony Markham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Markham, Anthony. (2022). Daridorexant: First Approval. Drugs. 82(5). 601–607. 56 indexed citations

2.

Markham, Anthony & Zaina T. Al-Salama. (2022). Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a profile of its use in the USA. Drugs & Therapy Perspectives. 38(6). 261–267. 1 indexed citations

3.

Simpson, Kerryn L. & Anthony Markham. (1999). Ofloxacin Otic Solution. Drugs. 58(3). 509–531. 30 indexed citations

4.

Markham, Anthony, et al.. (1999). Orlistat. Drugs. 58(4). 743–760. 81 indexed citations

5.

Langtry, Heather D. & Anthony Markham. (1999). Fluvastatin. Drugs. 57(4). 583–606. 64 indexed citations

6.

Dooley, Mukta & Anthony Markham. (1998). Pramipexole. Drugs & Aging. 12(6). 495–514. 65 indexed citations

7.

Brogden, Rex N. & Anthony Markham. (1997). Fenoldopam. Drugs. 54(4). 634–650. 57 indexed citations

8.

Davis, Rick & Anthony Markham. (1997). Ziprasidone. CNS Drugs. 8(2). 153–159. 21 indexed citations

9.

Wiseman, Lynda R. & Anthony Markham. (1996). Irinotecan. Drugs. 52(4). 606–623. 106 indexed citations

10.

Davis, Rick, Anthony Markham, & Julia A. Balfour. (1996). Ciprofloxacin. Drugs. 51(6). 1019–1074. 333 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact